Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04575870 · ClinicalTrials.gov registry record
Return of Aspiration-Free Swallow After Laryngotracheal Anesthesia
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 30
- Enrollment target
NCT04575870: Completed study, sponsored by University of Alabama at Birmingham.
NCT04575870 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04575870 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Patients undergo laryngotracheal anesthesia (LTA) for a variety of in-office laryngology procedures. Prior to resolution of laryngeal sensory anesthesia, oral intake may predispose patients to aspiration. The purpose of this study is to objectively characterize a time period for return of aspiration-free swallow after LTA.
Primary Outcome
A modified functional endoscopic exam of swallowing (FEES) is an examination where a small amount of water will be ingested. Each subject will perform about three water swallows. Water will be dyed with green food coloring to facilitate visualization, as is standard with the FEES procedure. If the water passes normally to the esophagus, this will be considered a pass; if the water is aspirated, this will be considered a fail.
Interventions
- OTHER waiting period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-11-18 |
| Est. Completion | 2023-01-31 |
What the finished NCT04575870 record still lists
NCT04575870 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which waiting period is the first listed.
NCT04575870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04575870 about?
NCT04575870 is a clinical study titled "Return of Aspiration-Free Swallow After Laryngotracheal Anesthesia". Patients undergo laryngotracheal anesthesia (LTA) for a variety of in-office laryngology procedures. Prior to resolution of laryngeal sensory anesthesia, oral intake may predispose patients to aspiration. The purpose of this study is to objectively characterize a time period for return of aspiration...
What is the current status of trial NCT04575870?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-11-18. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT04575870?
The interventions under investigation include: waiting period (OTHER).
Who is sponsoring clinical trial NCT04575870?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI